SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-04-063823
Filing Date
2004-04-16
Accepted
2004-04-16 14:48:59
Documents
1
Group Members
MDS CAPITAL MANAGEMENT CORP.MDS LIFE SCIENCES TECHNOLOGY FUND II NC LIMITED PARTNERSHIPMDS LIFE SCIENCES TECHNOLOGY FUND II QUEBEC LTD. PARTNERSHIPMDS LSTF II (NCGP) INC.MDS LSTF II (QGP) INC.MICHAEL CALLAGHANMLII (NCGP) INC.MLII CO-INVESTMENT FUND NC LIM

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D dsc13da.htm SC 13D/A 304364
  Complete submission text file 0001193125-04-063823.txt   306669
Mailing Address 1360 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1360 O'BRIEN DRIVE MENLO PARK CA 94025 6504625900
DEPOMED INC (Subject) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-53683 | Film No.: 04738094
SIC: 2834 Pharmaceutical Preparations

Mailing Address MDS CAPITAL CORP 100 INTERNATIONAL BLVD TORONTO ONTARIO CANA A6 0000
Business Address
MDS CAPITAL CORP (Filed by) CIK: 0001229595 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6